Clinical Trials Directory

Trials / Completed

CompletedNCT05978011

2014TP001 - Assessing the Biology of the Injured Lung - Version 1

Assessing the Biology of the Injured Lung - Version 1

Status
Completed
Phase
Study type
Observational
Enrollment
119 (actual)
Sponsor
Manchester University NHS Foundation Trust · Other Government
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Not accepted

Summary

Respiratory diseases are very common and are the third leading cause of death in England. As such, there is strong interest in understanding how respiratory disease occurs. This study intends to understand the changes that occur within diseased/injured lungs obtained from humans. The end goal of this will be to create new drugs to help treat these disorders. Diseased lungs will be obtained from patients receiving a lung transplant. Lungs will either be placed onto a heart-lung machine, or surgically cut in order to create a model of the lung that can be used experimentally in the laboratory. Using a heart-lung machine, lungs can be maintained outside of the human body for a maximum of 12 hours, allowing the direct assessment of the organ. Using this procedure, we aim to understand the processes that occur within a disease, as well as during repair. Using the model of the lung, we will look at how the body's immune system interacts within a diseased lung.

Conditions

Timeline

Start date
2014-08-29
Primary completion
2019-04-04
Completion
2019-04-04
First posted
2023-08-07
Last updated
2023-08-07

Source: ClinicalTrials.gov record NCT05978011. Inclusion in this directory is not an endorsement.

2014TP001 - Assessing the Biology of the Injured Lung - Version 1 (NCT05978011) · Clinical Trials Directory